Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci Office Hours
Recorded: Aug. 25, 2025 Duration: 1:04:10Space Recording
Full Transcription
I'm a good man.
Yeah, just looking at the craziness around Abreyai launch.
Did you look at what's going on with Abreyai launch?
Yeah, just looking at the craziness around Abreyai launch.
Did you look at what's going on with Abreyai launch?
Yeah, I looking at the craziness around Dobri launch.
Did you look at what's going on with Dobri launch?
Yeah, I mean, it's basically first thing in the morning for me.
So I have been trying to keep abreast, but maybe catch me up how things have been going so far.
The birth of an ai agent
it's uh when i looked a few uh let's say uh 10 minutes back it was 5.1 percent 5.1 x
over subscribed uh whoa 500 times like 500 times no 5x 5x yeah like wow a full 5x yeah i'm gonna i'm gonna look at it again what's the status
it's just like constantly you can see like you know uh bio coming in and now it's 6.4x
uh yeah and still we have 19 hours left yeah just started basically yeah that is crazy this is crazy yeah and you can see like constant uh dollar bio getting committed to uh this is
gonna be one of those uh you know pivotal moments for let's say months long waiting for the agent tech launch super happy to see it
in making finally it's happening yeah this is i mean like you said it's a pivotal moment
we've been a lot of a lot of agents in the works a lot of launch launch pads and launches prior to this but this is like
history in the making and we're living it it's crazy it is i don't know like it's gonna be
going up and up from now on um and i think like i've been enjoying uh the last couple of days
with uh like you know uh generating hypothesis uh digging deep into the
the longevity scene with obriai it's been fun it's kind of uh different from talking to chat gpt which
you do it on let's say just chat gpt window but now you get to do it on x and you can like create this mind share people can uh
instantaneously see all these new hypotheses being born out um yeah it's it's very interesting and on
top of that you have this proof of invention uh which is basically securing your idea instantly
as obrii generates this i think this is all, it's taking it to the next level altogether.
Yeah, I've really enjoyed the like building out loud that Aubreyi has kind of facilitated.
I know I personally learn a lot by just like seeing the form of a lot of people's like
hypotheses and questions.
So seeing some of the early contributors who were like,
oh, I'm going to test this out.
And then I'm like, I want to get in on this.
I want to test this out too.
So I think thanks to those people for, you know,
setting the standard and then allowing us to continue to build on it.
I think that that's what the like bio and molecule thesis
is kind of going for is this acceleration.
More people learning faster is
really cool.
Yeah.
Yeah.
All right. Sorry, we skipped intro.
Yeah, but maybe before we get
into it, we talk about who we
are a little bit. What is everybody doing here?
We're so excited about Abre AI. We had
to instantly talk about it. Yeah. All right. I'm Kehoe. I'm working as a consultant for Molecule.
I'm also a co-initiator of MicroBandau. And I'm reporting from south of India.
It's half past eight at night. And yeah, nice summer weather. How about you, Karlyn?
And, yeah, nice summer weather.
How about you, Karlyn?
And I'm Karlyn.
I am also a consultant at Molecule.
Kiho and I, you know, started in the D-Site space, not at the same time, but pretty close to each other.
We're basically twins.
I'm also a pump science dev with BXB and have been involved in a lot of the, you know, going to be involved in a lot of the
upcoming IPT launches from Molecule 2.0. So yeah, I'm in Chicago. I'm currently at Northwestern
University where I'm getting my PhD. It's a beautiful day. It's about 10 a.m. Chicago time.
And yeah, the sun is shining. It's so nice out like the
temperature that I really just want to leave lab forever and go on a walk for hours today
but I'm not gonna. I'm gonna stick here and chat about Desai. Let's get into it.
Awesome. All right today I want to keep it all about air agents because it's a hot narrative so yeah let's
let's kind of do a deep dig as we do usually into how obrihei and other bio agents that's coming up
kind of uh would change the the ecosystem right like because you have seen bunch of
air agents coming out but this is very different and unique in a way that you are bringing air agents for let's say healthcare biological sciences right
like specifically for that and it's not kind of restrained to just the scientific community now
you are making it open for everyone to go dig into it and following up from our previous conversation where we left last week
this kind of kind of gets into that like you know what would happen when people you know general
folks get these tools to become scientists like if you have skills of a scientist being analytical being inquisitive being curious uh and now you have
those tools uh what would this world look like you know so let's dig into that let's go um first dig
into obriai and let's see how this could play out in the future for let's's say, D-Sci and longevity altogether.
I want to start with a question.
What happens to these hypotheses that Obrei is generating?
How valid these are, like how this can be pursued?
What do you think?
So it's interesting because, sorry, I'm getting over a little bit of an illness.
The Abre AI, I've seen it, it's producing all these like proof of inventions, these hypotheses.
it is a testable hypothesis and it is based in, you know, a true review of the literature,
not just, you know, some things that AI can kind of hallucinate sometimes, then I think
it is a valid hypothesis that deserves to be sort of moved to the next stage.
Maybe there's some sort of vetting process that needs to go into it just to make sure
it's something that makes sense before it's actually tested. But as long as it is something that
is testable in a way that doesn't hurt others, I think it should be moved forward.
Maybe a great, I think we talked about this a little bit before. A great way to do that is to try to get, you know, some of these more open access and like
bounty style research things like research hub out there to, you know, get people to
test these hypotheses.
When you have people that aren't like necessarily experts or come in with that the love the base understanding
of some of the biases of these different uh areas you get things that maybe at first an expert would
be like oh this doesn't really make sense but if as long as it's rooted in literature that that is
you know verified i think it's it's something that's worth looking into further
that's worth looking into further.
Awesome.
So actually I'm looking at the OBDII dashboard right now.
So there have been 688 hypothesis generated so far
and 805 POIs minted so far.
So 805 POIs, which is basically unique ideas,
which let's say you own, if you could prove, So 805 PivoIs, which is basically unique ideas,
which let's say you own, if you could prove,
this is basically a proof of invention,
which you can take this hash and then you can prove,
okay, I came up with this idea first and I get a leading edge on pursuing this idea.
If someone kind of takes it up and pursue
you can again go and say okay i came up with this first right like sort of to um argument that yeah
you own the proof of this particular idea right in that case we have 805 now and how the streamline
will happen uh how would you you you know, pick those top,
let's say top five or top 10, top 100 hypothesis?
And where should we take this next?
Should we take it to academics to kind of vet
whether these hypotheses are legit
or is this, you know, feasible to pursue further?
Is it a good shot?
You know, can we look into this? How would you take this
further, right, starting from the POIs? Starting from the POIs, I think maybe to start off,
academics, I think, would be a good vetting system. But if, you know, if we really want to bio-act, if we want to accelerate,
we want to get to a point where that can be agentic as well. And so our agent of the day maybe is a,
and this maybe already exists, a like IP tester. Because, you know, it's one thing for a separate system to be able to mint like a POI, but what if you, you know, then look a little bit further into patent literature
and the, you know, one of these, you know, agents is able to see that someone, you know,
mentioned this in a prior patent filing many, many years ago.
And so they are now, you know, it's no a prior patent filing many, many years ago. And so they are now,
you know, it's no longer actually an innovative or
idea. You know, maybe you now have these, these academics that are like, oh, yes, this is something
that is not been thought of by people in the field before. So it's actually something worth, you know, moving to this next phase.
And then, you know,
now we have these agents that can then be like, Oh, we're we've seen 10 ideas
that are like this. Let's check it against each other.
And then whichever one is the most sort of not has the like highest novelty
score or something like that can then move forward.
That's maybe sort of like an early way
of kind of moving from the,
moving these 805 POIs to, you know,
the ones that can really become ideas
that can be followed up on in a commercial way.
can be followed up on in a commercial commercial uh way
awesome yeah thanks for walking us through that so probably then the next steps would be once you
streamline that uh you can take it to a testing like a real lab you put this hypothesis yeah maybe We then expand pump sciences influence and they are like instantly able to test whatever
these different hypotheses are based around longevity.
The order gets automatically filled as soon as one of the POIs is proved to be a truly
novel idea that makes sense and has sort of a market that it can go to.
Awesome. Awesome. Let's talk about the real uniqueness of Aubrey AI because it's being modeled out of Aubrey de Grey, longevity expert.
So I think
Aubrey is being trained with his
personal notes, his lab
notes, his emails and stuff
like that to make it sound like
Aubrey himself.
imagine a future
where you have
experts like Aubrey and few other Nobel laureates or like leading rock star scientists like Rob Knight or even like, you know, interesting personals whom we look up to in the scientific field.
look up to in the scientific field imagine making an agent out of all of them or at least like few
of them and then you could then create a chat room right like then start a hypothesis right like
start a first initiated question and then make them debate on it and come up with a new novel
idea how would this play out well that's instantly when you bring up bringing a whole bunch of different like, quote unquote
consciences of these like academics together, I get like chills thinking of the weird mega
knowledge monster that could come out of that. We would need to make sure that they could not become evil scientists,
evil med scientists right away.
But I think once we, you know, instilled in them some, you know,
some morals, so to speak, it would be such an interesting way to, you know, one, simulate the sort of feedback you get from
like a lab meeting. So sort of like a virtual lab meeting of your ideas. Some of the best
feedback I've ever gotten in my PhD, while I've been pursuing my PhD, have been in these
sort of like, you know, one on one,one, one-on-five, one-on-one-six sort
of situations where I just kind of lay it all out there.
All the evidence that I've seen and getting that feedback has been probably the most helpful
in figuring out the direction of where I can go.
So I think that playing out in an agentic way is, especially if we can keep it sort
of like how Aubrey AI currently is, that it's like all these different tweet threads
that people can just sort of follow up on.
You now take that closed door lab meeting and bring it on chain and in front of everybody
so that now it's like, oh, we're not just one on six.
We're now getting a thousand on a thousand. And
that, you know, can amplify each other to, you know, exponential degrees, which I think would
be a really, a really smart way to utilize the, you know, the knowledge of all these great
scientists. I'd love to get, you know, David Baker or somebody like that to maybe a part of,
David Baker or somebody like that to maybe a part of in the future,
part of being a Nobel prize winner is that you have to agree to become an
agent or something like that.
That would be crazy to be able to like capture that knowledge for all time.
Yeah.
Especially because, you know,
the fact that this Aubrey eye is out of lab notes too.
I think it's really interesting because a lot of what people end up seeing
from some of the best scientists
is they're more published,
they're more polished publications
and talks that they've given
that are the end result
of a lot of very, very long years of work.
And to see sort of the connective tissue,
I think would be very enlightening
and educational for people to understand how science actually works.
And also to understand that, you know, the people that these agents were modeled off of are, you know, are not these, you know, godlike science creatures.
god-like science creatures, the human beings that probably very likely made mistakes and,
you know, doubted themselves along the way, but persevered and, you know, created, you
know, discovered new knowledge that helps the world, which I think is really inspiring
as well.
Yeah, definitely.
I think I'm also on the track to bring on board more scientists yeah this um
you know like to to create this uh infinite corridor like uh infinite rooms of uh infinite
chat rooms for these agents to discuss on uh infinite number of things and see what comes out of it.
That is something that I would be interested to see in future.
And yeah, I think a lot of things are possible with this agentic future,
especially with bio agents looking, you know,
looking uh you know take a deep dive into especially for longevity um imagine if uh
take a deep dive into, especially for longevity.
you know like one obray working on solving the longevity problem and uh compare it with uh
thousands and thousands of obrays working to solve the longevity problem compounded with their own
brain power and the ai's compute power uh i don't know we might solve we might end
up solving longevity aging issue all yeah i'm i'm kind of bullish on this i think um i've liked a lot
of the hypotheses that i've seen crop up in in just this like last weekend of people starting to
starting to test it out um and i think that that's just gonna continue to,
that number is gonna continue to grow as the,
you know, the agent becomes smarter
from all these different people contributing their knowledge.
Yeah, definitely, definitely.
Yeah, let's dig further into the bioagent ecosystem.
What else is on the docket?
Lay some off for our dear listeners.
What's going on?
Exactly.
I don't wanna shill my own project,
but since this is also on the list,
I would just briefly touch upon this
uh to at least like these are here what's coming up next um so but before that please go check uh
bio xyz for obre ai launches live uh the sale the ignition sale is live. So feel free to go take a dig at it.
And next up, we have a couple of agents coming up.
One is DigGPT from DigDAO.
And the other one is BiomeAI from MicroBandDAO.
uh biome ai from microbeam dao uh yeah so dick gpt is gonna be your uh you know like
Yeah.
if you have that like it's gonna help you uh estimate your dick's age or any sort of
problems i love it so yeah it's it's it's trained with a bunch of scientific literature
specifically on men's health so it's gonna be
your personal sidekick to yeah to help you you know what compounds works best and um yeah what's
good for your that's so interesting does dick do you know if dick dow does anything related to like
men's fertility as well i know that's a pretty common issue that a lot of people don't talk about, but it would be a really cool use case.
Yeah.
Yeah, but they're primarily focused on...
Hey, that'll happen.
Yeah, for sure.
Yeah, probably I think fertility is also under their umbrella of approach.
I had a call with their founder a few days back.
with their founder a few days back.
So, yeah, I think they are doing a whole arching view
on general men's health.
So probably we'll see a couple more projects
coming out of DIGDAO.
And yeah, we are also like,
so he also mentioned that he wants to launch
a pump science compound to really push for mitigating erectile dysfunction
symptoms.
I asked him, what could be the endpoints?
What are the observations that you would look at the mice?
Are there any-
Rigid worms.
That we could like-
But they're still alive no it's not possible in the worms uh yeah you you need to skip uh directly to mice because
you need to go there uh he he said like they would then put a rod on this and measure
um you know uh some muscle contraction but then they will also measure like uh you know
the the size of the testes and stuff like that yeah yeah blood flow and other stuff uh i'll be
curious to see you know like if this is gonna happen um i'm interested uh in this and uh apart
from that like moving on to biomei uh the project that i'm kind of involved
you have full permission to shill please tell everybody about it yeah again uh nfa not the
financial advice uh but just like you know talking about the product in itself so biomei is trained
with over thousands of microbiome related articles uh scientific literature and real user
stories uh that means it's a it's a curated chat gpt specifically for gut health and uh i know like
bunch of folks here including me goes to chat gpt to discuss about their personal health and
you know like track their biometrics and stuff like that which I also used to
do and then if you think about the question of you know how truthful these
agents are this GPT is it's yeah sometimes they just tell you what you
want exactly it can do anything to please you right like you appreciate it a protocol and it will say yeah
i want you to be great so
exactly this issue is there so that's why we built biomei which is gonna uh provide you with keep it real uh site uh yeah site where this information is coming from. It's basically real science for real people, right?
Like, so this is one part.
On the other side, you have users
because science is something that's coming out
of all these work done by scientists at lab.
They'll look at a bunch of different mechanisms on mice
and do some interesting trials on humans.
But do we
is it true that this particular invention or scientific discovery
works for everyone? That's a very deep subject.
Yeah, I feel like that's not true for any.
That's why Biomai is going to be.
Any treatment doesn't work for everybody.
Exactly.
Because because I think like even during my conversation with
obrii it came up with something saying that okay i i asked it for a longevity protocol
uh focused to boost you know like gut bacterias that are found in uh people who live more than hundred years and Aubrey I came up with a small a quick hack which is eating
broccoli every day and along with another other compound so then I digged
into it and then I found okay most of the South Asian population lacks they
have a specific gene polymorphism like a mutation which kind of affects this absorption
of the active compound in broccoli which is sulfur ruffin because of this this protocol
will not work for south asians whatever uh was suggested so and then i i highlighted this
yeah so i highlighted this part uh to obriai and it came up with a different hypothesis to mitigate
its effort effort effect so yeah this is the issue right like so that's why we thought of
building more sort of a user-driven journey so let's say you and people like you with the same
microbiome profile or same activities come together and run a small micro trial at home
like you know you'll be just reporting like i ate this and that and the ai will look into this data
the anonymous cohort data and come up with a hypothesis which is not coming from scientific
papers but from real people so it'll say okay looking at these 10 people i found out i found out a pattern that comes out and say okay um eating
certain food or uh stopping stop drinking coffee after 3 p.m kind of improves the trading performance
something wild as this could be possible right like so that's the whole goal of it like have a
science-driven hypothesis like science driven knowledge graph,
but then also build another parallel knowledge graph,
which is user driven.
Let's combine these two worlds.
Like one is objective, the other one is subjective.
How can this, you know, what will this evolve into?
Right? Like that's the whole question.
So that's exactly what we are building.
Cool.
Kind of combines the like standards of a lab protocol with the randomness that we experience in our regular communities, which is really cool.
Exactly.
I love that.
And yeah, let's see.
And I saw you are on the signup.
Oh, yeah. I saw you you waiting on my dm brother
yeah you need to wait like i guess like within a couple of days you will be able to test it
let me know as soon as that goes out because i don't want to miss it
definitely yeah yeah uh but the the thing is is you can only discuss non-personal information on X and Discord with BioMai. If you want to do any personal information, you cannot do it on Twitter because as you know, the data that you put on Twitter belongs to Twitter and same with Discord. So you need to use our web interface to kind of then talk with your data,
personal health data.
Cool. And that's just on you guys' website?
Yeah.
Sweet.
I'll show you that as well.
Sweet. Please send that.
And yeah, so imagine like
we just scratched the surface of bioagents.
Yeah, I mean, just a few already like you, but already solving.
Yeah.
But imagine the kind of, yeah, the magnitude of impact that these agents are going to bring
into this scientific ecosystem, but like in general life as well.
It's early.
And on top of this, you have this interesting structure, which has been less experimented,
which is, you know, a tokenized model, because these agents are instantly tokenized as it
gets launched.
And that means it's owned not by a single owner like Sam Altman or, you know, Jeff Bezos.
It's owned by the collective,
collective of people who kind of invested into this.
So because the project being a collective,
I don't know like how this dynamics would play out.
Probably when some crazy invention comes out,
this collective will become a syndicate or, you know,
they will choose to make it open source
for a whole of the world. don't know i'm i'm
i'm just kind of bullish on this uh or like super excited on this um you know tokenizing assets
and how this is going to play out because for other other things it does make sense but when
it comes to knowledge asset and specifically things like uh you know
biological sciences that touch closely to health care which impacts our health in real time uh
this is sort of a sensitive matter and i think all those token holders will take responsibility to
for the safe handling of uh you know whatever um intellectual output that's coming out of it.
Yeah, there's a lot of incentives involved,
but the greatest one I think is living better,
which I think we can all get on board with.
Yes.
Nice.
Awesome.
All right.
Yeah, we scratched the surface of bioagents today.
Yeah, maybe if you guys are also excited, but you're not yet a speaker, comment below this post what you're excited about of the coming AI launches and Abre AI and stuff.
Awesome. Hi, Vexa. How are you? How was it?
Hey, Vexa. Long time no see i missed you yeah i missed
you guys too hello keeho carlin oh i'm seeing pump.science is bringing this whole unified um
compound launch and it's amazing then the ai ai the obri AI that just launched today it's interesting
yeah and it was amazing it was interesting but you know it's made me
understand that many persons don't know about this eye. I was there with Marc Anthony and Zika here.
So I talked about this eye to many persons
and most people don't understand,
but a few persons were intrigued.
They were like excited about it.
And yeah, they wanted to learn more about this eye.
So I wanted to join the Akaton too yeah with sql cell dow well i couldn't
find devs they thought it was some sort of ngo or something so but i think i got some developers
to join my team so i'm still building the technical team but it was interesting and i missed you guys
too i missed like you know the familiar space of this eye where everybody knows about this side
out there people don't really know so you have to like
yeah that awareness yeah the awareness what what's your elevator pitch for this side what's this side okay this
side is it depends on the person that is actually asking if you're asking from a researcher point of
view i'll say decide for you it's a way to make science easier make you um do more work and less asking for funding for your clinical trials.
It helps you apply AI to your research and gives you more results.
And it helps you also collaborate with people around other scientists
and helps you get feedback from the community.
So from a citizen so i explained
this according to so it should be relatable to the person i'm talking to basically great pitch
yeah that's the best approach great yeah definitely it's something that you know you
got to meet people where they're at and so what what will, you know, pull the most at these people's heartstrings?
And for most researchers, it is making the things that get in the way of the science
are what frustrates them the most.
All right.
We have Macan.
Yeah.
How are you doing, my man?
I'm good.
Can you guys hear me?
Yes. Okay. how are you doing my man i'm good can you guys hear me
okay uh gm everyone i am good how's going keo carlin i still remember you carlin carlin do you remember me i do remember you yes you did say
we did say you said i forgot or i I didn't really care on the Discord chat.
I was just joking, man. I was just joking. How's it going?
Good, my brother. Good.
Nice. I see a lot of improvements, a lot of new updates on the D-Sci ecosystem.
system uh i and uh vex uh joe uh joe marais a couple of other people as well just trying to
work on something you know something really coded for the african you know de-sizing
as a decide yeah it's quite um new everywhere obviously but in africa it's like it's like
really behind.
So obviously we are trying to like increase the awareness around DSI in Africa,
you know, bring a lot of researchers, a lot of students, a lot of people on board as well.
So beyond that, you know, it's really nice to see at least in other parts of the world, you know, DSI moving.
And yeah, basically super happy to be here as well.
Yeah, you guys are the trailblazers for Desai Africa.
Keep it up.
Yeah, of course, of course.
Yeah.
Yeah, I think...
I'm super proud of that.
Sorry, sorry, Kiho.
I think Mark was actually telling me about an event that is happening in Lagos, Nigeria.
It's like one of the top events and he's trying to build a kind of this side hub that will connect this side to the community.
So Mark, can you buttress on that?
Oh yeah, of course. I totally skipped my mind.
So there's a festival, Unchain Festival coming up.
And like it's one of the biggest Web3 events in Africa. And this year it's been hosted in, of course, no other place
than Lagos because that's like the biggest hotspot for DSi currently. So it's an Unchain
Festival. It's quite big, but the uniqueness about this particular event is that it has a wide range of speakers and guests, basically.
So it cuts across healthcare, it cuts across Bank of Industries, it cuts across Web3 as well.
So they're trying to merge all these industries together. In my head and in my years of working in Web3, I see an opportunity here to basically try to debut what DCI is,
especially since the audience is going to be mixed with health people and with Web3 people as well.
Like with Web2, health people and Web3 people as well.
So I see an opportunity here to kind of work on something and then sort of debut debut what this is and what the product is and all that stuff at that event.
So, yeah, that's basically the update Vex was talking about.
Sounds like a great opportunity.
I did not know that Lagos was the crypto hub.
So definitely that opportunity is
going to be huge for continuing
to raise awareness. Good luck
to you.
Lagos is quite huge.
If you guys need any
extra eyes on
the materials that you're
going to have with you,
just let me know. Happy to
take a look at it of course of course
yeah and um i'm super happy to see uh mac going um you know full spree dc maxi
yeah here uh we we kind of been uh sparring partners during the DSI ADU course and I mentored him for some time but
back then he also mentored me back on with free stuff so yeah happy to see that you really are
carving your path in DSI it's a long way to go and consider this you know this is this is your moment man like this is your
moment if you are in dsai this current dsai bull run is where you would capitalize on everything
be it your project be it your token be it your social clout this is the time for anyone who is
building on dsai so make sure you use on it make sure you don't sleep on it. You know, yeah, don't miss this opportunity.
It's for everyone there in the space.
Okay.
When is the next DSAI EDU cohort coming up?
Because I'm feeling impatient already.
We don't know yet.
I think Kehoe is actually going to be doing a little bit of dsai edu stuff
soon but it will not be the next cohort yeah i'll be yeah i'll be doing a dsai edu uh incentive
program intensive program at uh network school singapore uh along with with my beautiful mentor Ella and yeah but but
interesting thing is we are cooking up a publication on DCI edu like how the
course went what was the impact and you know how this kind of made a change in
the DCI landscape and all of that in one publication.
So, yeah, we just finalized the draft today.
Looking forward to the publication coming up soon.
And once it hits the ground, make sure we'll discuss that impact and how to scale this.
Because I think this is a very important uh part of building the dsci ecosystem
targeting the young uh academics and you know folks who are coming into crypto uh building dsci
as the next big narrative in the in the web 3 world so for that you need like systems to onboard
people into this sort of dsci education uh looking into how the ecosystem is different from
other d movements so yeah i think this model is gonna be useful for all different communities
across the world to pick it up and fork it and build their own sort of dsci edu hubs
it and build their own sort of dsai edu hubs uh across the globe so yeah stay tuned for that paper
uh which is going to come out very soon a lot of lessons a lot of learnings over there
you could use this as like your basic you know um first print document to to spin up a new course
out of it so a lot of content has been put up and there's a lot of time and effort into this.
So yeah, stay tuned for that.
So exciting.
Thank you so much.
We don't know yet next time, so sorry.
What did you say?
Please continue.
Sorry.
Colin, I think you were saying something. something no I was just agreeing with Kehoe please go ahead okay I wanted to ask oh I don't know use for
sickle cell dow like the tower I'm currently founding it's I don't I think
I'm stuck in a way because yeah from the community building we are still
building the community and i'm about getting but the content is still going out in the page we are
currently at 104 followers currently so and i'm yet to onboard the researchers and doctors we have a pharmacist already and
we have a doctor already who is also a sickle cell warrior so um how do I
onboard the doctors to the sickle cell would they be submitting their research
papers through the DAO to Molecule DAO or Research
Hope or how do I go about it? That's my question.
That's a great question and I actually don't know. Kehoe, do you know?
I can take this. I can take this, yeah.
So you basically start with either, so two things you need two things for any
dsi project one uh is the problem or your focus area that you are building this dsi project for
for example you can look at retada which is for longevity or you can do a look at athena for
women's health for example so you need to identify
that which you have done already the first part sickle cell and uh so now you know like what's
the problem that you are trying to solve and now you need to know whom you are solving this problem
for basically people who are going through sickle cell uh symptoms and and suffering through this
right so you put these two things together,
the problem and the people who are going through this problem as their daily
life issue. And then once you have that,
you need to bring this collective to capitalize on this collective. Uh,
what sort of things you can capitalize? You have valuable patient information,
which is your community's information you can create these patient information
you can attract investors to look into this information you know use that investment to
find scientists or fund scientific projects and it cannot be one man effort effort you need to
find relevant people who are good at finding these you for you, researchers for you, or even labs
which could run these experiments and trials.
So I think you have done basically the first couple of steps
and it's just like matter of bringing in the right people
who can support you and match the skills that you have.
So yeah, that's how I would go about it.
Okay, thank you so much.
Was it helpful?
Yeah, it was.
Yeah, so I'll have to bring in the researchers,
the lab scientists.
So I think I'll do that.
I'll try doing that more and better
awesome yeah and again i see my rosin on the space i think i heard him talk on raptor space
that was yesterday hi nice to be here yeah i, I was listening to you. I was seeing that it's a space on
this side. Oh yeah. So we should join as much as possible, the devs and the one that are
in the space. Yeah. That's my opinion. As louder as we are and as more communication we have to first of all to each other and after that to the
community will be will be a good point to take in the future will help us build faster because
the speed is is the only the only variable in my opinion because all all the people all the big projects in
in descent in this this eye uh they are building behind and community doesn't see that but they
have to wait until something leaked or something it's officially out and you can also join the next project but I'm quite sure and as I know
from other devs that I'm talking to that there are a lot of things happening and lots of things are
evolving in different speeds but the most important thing in my opinion is to to stay there to to continuous to continue to
to improve what you do and to continue to develop the speed yeah it's it's variable
from team to team and from resources to resources but it's super great to be here thank you
but it's super great to be here thank you if you have a question regarding bomb science or
any anything i i should yeah i i will try uh answer cool thank you so much for joining us i
i totally agree i'm i'm building right now i'm yeah i, but with the headset on my ears,
I can still hear you and maybe, yeah,
contribute a little bit to the discussion
as much as I can.
Fantastic.
That's the spirit.
That's what we need in the outside.
Building in the open.
Building a more robust community. Not not just faster but also deeper connections 100 yes
yes tell us more about meteors yeah maybe i've seen it's uh the compound that i
choose in order to participate at the competition, on the compound competition on BAM science experiments.
We are in the lab right now.
As I know, the compound was administrated to the worms.
Super excited to find out what's the outcome of our compound.
We choose the Mediosyn because it's something natural that it's from a
fungus based in japan and also uh brings the the the research from 2014 and other official researches show super wow big improvement in lifespan of the sea elegance worm
and we we can cannot wait to see the results they will come maybe in a couple of days or weeks i don't know hope hope will come after two months so our worms
it's are still alive for sure are still alive in this moment but yeah the compound it's different
from other compounds already launched on pump science because we approach a different type of
pump science because we approach a different type of
Lifespan improvement they they approach the mTOR most of them approach the mTOR inhibition in order to
achieve the the greater
lifespan and the best curve possible but we
We focus on myriotin is focusing on the sphingolipids there are some
some molecules in inside that need to be as it's like a cleaner it's a not a detox but it help
improve when when you um let me put it in the way like i i explained to a five year year school kid
sphingolipids if the sphingolipids are your power plant you are a city your body is a city and
sphingolipids are your power plant uh mediocin uh as as you get as get old enough, the sphingolipids are multiplied in your body.
And myriocin, clean them up.
Don't let them jam the streets and the cables and the power plant and in this way you thrive more and live better and age less
or slower um the the first the first objective is to have a super good
result on the sea elegance experiment and after that if we have a positive, for sure we have a positive.
I'm 100% it will be super positive, but I'm expecting to be as high as possible.
After that, we can decide and we can know for sure that Meteos scene alone can improve lifespan of c elegans and after
that we can mix it with rapamycin and we can build together and test until we achieve
a new conclusion and after that on and on we will do it we'll do it just just just to find out how what what's the best option and you
you can find out what's the best option if you just try it without trying it you will never know
so that's that's why we are here and it's a it's a marathon it's's not a sprint. So, yeah, we are building as hard as possible and focusing as much as possible.
Awesome.
Great explanation.
Thanks for sharing information.
Yeah, maybe my English is not quite good because I was learning French and German, but I'll try my best.
It's perfect.
No, don't do that.
It's great.
It's great.
That's really fascinating.
Awesome.
Yeah.
I, I'm going to check out Mirios and a little bit more.
I, uh, you should do that because we are in a small group here.
We prepare a big project that will be launched and as i uh as i always
tell anyone that asks me about blockchain and the biotech and the communities because i'm
i'm quite old in in in blockchain i'm a djn back in 2019 18 19 there oh my god that was like uh i i was i was i was like uh full job
time uh maybe more than a full time job because i was spending hundreds of hours per week at the pc
researching it and learning it and of course but uh yeah what i'm
telling you before it's that being early it always pays off that's the that's the side of the project
with the because it's a mix it's a mix between biotech and also crypto and the projects from crypto are based on the communities and about culture and about sharing the same vision
but also in biotech you have to have the solid base of the science and if you want to mix it, of course, the scientist guys that are more nerdy and good for them
because they are more smarter than the DGENs need to fusion with the crypto guys, you know,
in my opinion.
And that takes time.
But if we share each other's thoughts and be 100 straight and sincere with
each other we will build something unstoppable in my opinion yeah and the the big project
it's happening soon and for sure there will be the first tier that will be rewarded.
There will be the two compounds we launch, myriocin and alpha-glutoglutarate.
More to come.
More to come.
Nice.
Yeah.
Cool.
And what's the ticker for myriocin?
Is it already trading on POMScience?
Yeah, of course.
Graduated a time ago.
The experiment is already live in the the lab as Benji from pump science
confirmed me that they all right have the substances the the compound and already
administrated as we ask him to administrate with the dosage and the days that they will need to be feed uh it's happening yeah it's happening uh medio it's the
ticker and the other one it's akg the ticker alpha ghetto glitter it's another compound it doesn't
excel at being alone as i saw because we already have the test for that yeah not on its own but it maybe has a combo right
for what is different from myriacine and alpha ghettoglutary is that they are totally
antagonic like myriacine it's a top tier for c elegans it's the most powerful substance, in my opinion, as I research it as better as I can.
It is the most powerful compound that you can administrate to a C elegans in order to life span it.
The alpha-ghetto-glutarate, it's the best compound overall because alpha ghetto glutarate you will
find also in the human body and it's a substance that that organized and
optimize the mitochondrial energy and it's it's totally different because myriacine for example
it's toxic for for people you cannot administrate it to people maybe very small dosage because the
kidney it attacks the kidney but the researchers found in 2021 that they can extract from myriocene a substance fingolimod it's the name and it's a
drug for ms for multiple sclerosis yeah and the the treatment it's getting some great results
in our country also because i know i know i have friends in science that's why i approach
the science part and i speak with my my closest friends from my country regarding this uh yeah
uh tell me more about you carlin about me yeah yeah okay cool. I'm a I'm Carlin. I'm a consultant currently for
molecule. I'm a scientist by training. I'm one of these science guys you talk about. I started with
molecule a little over a year ago, last May, as a sort of like venture fellow to sort of help them with
their initial catalyst offerings, became fully de-side pilled. I'm now, like you, a drug dev
for Pump Science. I launched BXB, which is bourbon and biotin. We uh like akg did not necessarily show the greatest uh longevity
increase in worms um but i i'm pretty i'm pretty bullish on the compound uh combination still
um if maybe not for longevity for um you know metabolic and hair health those sort of applications stamina stamina and
exactly stamina stamina and power exactly exactly and you know just like maybe so then maybe
incorporating a little bit more endurance yeah and you know I'm you know really into a lot of the
Yeah. And, you know, I'm, you know, really into a lot of the issues that DSI solves, like funding and, you know, the sort of like bureaucracy that you have to go through with all these like university projects.
I really like that it's open for anybody. You know, I went through all this work to get a Ph.D. just to realize that, like, you know, I'm not necessarily I don't think I'm necessarily smarter than any, anybody that doesn't have a PhD. I just have the, you know, the stick-to-itiveness
to stick to a project for a long time. And so I, I completely understand the value of,
you know, getting the cross-functional, like these different ideas from different people with
different areas of expertise. And I just, I really love the fact that Desai is the place that all those things can come together for the betterment of humanity.
So I, you know, that's my, that's my little shield on how much I love it.
And yeah, I'm happy to be here and happy to be able to meet people like yourself.
You're, you're, in my opinion, you're, you're on the right road because in time, I was doing performance sport.
I was a fencer for 18 years, like a pro. That was my job to be a fencer in national team,
but just a side part of it. I love it very much, but it's a different story.
part of it uh i love it very much but it's it's a different story um if you if you have passion and
if you do it every day and improve yourself one percent every day that compounds and after one
year you overcome lots of guys that are running with a small pace time to time or do a sprint.
But if you do the marathon and you just keep on doing it, in time you overrun it, overperform it.
And yeah, that's the way.
In my opinion, that's the success way.
I met such a lot of people in in sport that are very
very passionate about it and work super hard and when the exam comes and you have to
have to show what you what you uh compound in you uh the the one that works a lot, many times beats the one that got natural
talent, you know?
Yeah, yeah, exactly.
I totally agree.
It's great to have the mix of them, but no one knows how you how where or when or in which family you are born so
yeah it's a lottery there but what depends on you it's to be uh consistent every day
yeah doing something that you like and as dalai lamaama said, if you do what you love to do, you will never work a day in your life.
Because you will not feel it's a work.
It's something that you like.
So it will pass and feed you more to do more and more.
Yeah.
I'm speaking too much.
No, it's beautiful.
Absolutely.
I can listen to you talk all day.
I love it.
Exactly.
I will join you.
We're here every week.
We're here every week.
Yeah.
Awesome.
We just need to wrap the call.
But a closing note.
I'm seeing Desai in action here because uh carlin is a
a seasoned scientist talking about meme coins and uh midosin uh i don't know who is behind this i am
behind i'm out there so okay the midos and dev is behind this and he's a seasoned degeny yeah valentine is a seasoned degeny uh building in
the trenches now entering biotech like with these we're doing it man i think this is exactly what
we wanted out of these and this is happening um so there is no stopping no keep going keep
just keep one percent every day i love that let's let's keep going ns equal to two hence proved
it was super nice to to hear you yeah thanks to you and thanks to everybody for coming up to speak today we really appreciate hearing what people are building in the space uh if you're localized
if you're localized in africa please uh reach out to bexa and Mark Anthony and, you know,
let them know you want to get involved and, you know,
keep spreading the word of Desai.
We need more foot soldiers.
Of course we will do so.
I'm in Europe, but yeah,
it's only the Mediterranean Sea between us.
That's it.
A big desert because you're in the south, right?
You're in the south of Africa or in the south of africa or in the
middle where are you based on uh they are based in uh nigeria nigeria so yeah west yeah yes super
nice never been to africa but i hope i will not die until I see it, you know?
For sure. Yeah, now we have Aubrey.
Yeah, that was questionable.
Now I have to leave it.
I have to do Safari.
I need my son next to me and see some wild things there.
It will be awesome.
Yeah, hope to do that.
But now-
All right, guys. working keep grinding keep grinding to
all our dreams keep grinding uh keep deciding uh see you guys next week until then bye bye
all right ciao All right, ciao.
